Publishing research using ab64212? Please let us know so that we can cite the reference in this datasheet.

ab64212 has been referenced in 6 publications.

  • Peng C  et al. Synchronous primary sigmoid colon cancer and primary thyroid cancer followed by a malignant tumor of the kidney: Case report of multiple primary cancer and review of the literature. Oncol Lett 17:2479-2484 (2019). PubMed: 30719116
  • Teissier T  et al. Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions. Aging Cell 18:e12850 (2019). PubMed: 30794349
  • Yang H  et al. Predictive and prognostic value of phosphorylated c-KIT and PDGFRA in advanced non-small cell lung cancer harboring ALK fusion. Oncol Lett 17:3071-3076 (2019). PubMed: 30867736
  • Hammad S  et al. Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation. Arch Toxicol 92:2549-2561 (2018). PubMed: 29974145
  • Filliat G  et al. Role of HTRA1 in bone formation and regeneration: In vitro and in vivo evaluation. PLoS One 12:e0181600 (2017). IHC . PubMed: 28732055
  • Planque SA  et al. Physiological IgM class catalytic antibodies selective for transthyretin amyloid. J Biol Chem 289:13243-58 (2014). PubMed: 24648510

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up